Pulmonary functions testing in patients with rheumatoid arthritis

Israel Medical Association Journal

Volumn 11, Issue 2, 2009, Pages 83-87

  Avnon, Lone S ^a   Manzur, Fauaz ^a   Bolotin, Arkadi ^a   Heimer, Dov ^a   Flusser, Daniel ^a   Buskila, Dan ^a   Sukenik, Shaul ^a   Abu Shakra, Mahmoud ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Mortality; Pulmonary function tests; Rheumatoid arthritis; Small airway disturbance

Indexed keywords

ANTIRHEUMATIC AGENT;

ADULT; AGED; ARTICLE; CROSS-SECTIONAL STUDY; FEMALE; FOLLOW UP; HUMAN; LUNG DIFFUSION CAPACITY; LUNG DISEASE; LUNG VENTILATION; LUNG VOLUME; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; RHEUMATOID ARTHRITIS; RISK FACTOR; TIME;

ADULT; AGED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; CROSS-SECTIONAL STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG DISEASES; LUNG VOLUME MEASUREMENTS; MALE; MIDDLE AGED; PULMONARY DIFFUSING CAPACITY; PULMONARY VENTILATION; RISK FACTORS; TIME FACTORS;

EID: 66149131034     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Anaya J, Diethelm L, Ortiz LA, et al. Pulmonary involvement in rheumatoid arthritis. Semin Arthritis Rheum 1995; 24: 242-254.
2. Evans SE, Scanlon PD. Current practice in pulmonary function testing. Mayo Clin Proc 2003; 78: 758-763.
3. Linstow M, Ulrik CS, Kriegbaum NJ, Backer V, Oxholm P. An 8-year follow-up study of pulmonary function in patients with rheumatoid arthritis. Rheumatol Int 1994; 14: 115-118.
4. Fuld J P, Johnson MK, Cotton MM, et al. A longitudinal study of lung function in non smoking patients with rheumatoid arthritis. Chest 2003; 124: 1224-1231.
5. Vegnengre A, Pugnere N, Antonini MT, et al. Airway obstruction and rheumatoid arthritis. Eur Respir J 1997, 10: 1072-1108.
6. Perez T, Remy-Jardin M, Cortet B. Airways involvement in rheumatoid arthritis. Clinical, functional and HRCT fndings. Am J Respir Crit Care Med 1998; 157: 1658-1665.
7. Gabbay E, Tarala R, Will R, et al. Interstitial lung disease in recent onset rheumatoid arthritis. Am J Respir Crit Care Med 1997; 156: 528-535.
8. Dawson JK, Fewins HE, Desmond J, Lynch MP, Graham DR. Fibrosing alveolitis in patients with rheumatoid arthritis as assessed by high resolution computed tomography, chest radiography and pulmonary function tests. Torax 2001; 56: 622-627.
9. Cortet B, Perez T, Roux N, et al. Pulmonary function tests and high resolution computed tomography of the lungs in patients with rheumatoid arthritis. Ann Rheum Dis 1997; 56: 596-600.
10. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthrtitis. Arthritis Rheum 1988; 31: 315-324.
11. American Toracic Society statement. Standardization of spirometry. Am J Respir Crit Care Med 1994; 152: 1107-1136.
12. American Toracic Society statement. Lung function testing: selection of reference values and interpretative strategies. Am Rev Respir Dis 1991; 144: 1202-1218.
13. Radoux A, Menard HA, Begin R, Decary F, Koopman WJ. Airways disease in rheumatoid arthritis patients. Arthritis Rheum 1987; 30: 249-256.
14. Cottin V, Tebib J, Massonnet B, Souquet P, Bernard J. Pulmonary function tests in patients receiving long term low dose methotrexate. Chest 1996; 109: 933-938.
15. Dawson JK, Graham DR, Desmond J, Fewins HE, Lynch MP. Investigation of the chronic pulmonary effects of low dose oral methotrexate in patients with rheumatoid arthritis: a prospective study incorporating HRCT scanning and pulmonary function testing. Rheumatology 2002; 41: 262-267.
16. Khadadah ME, Jayakrishnan B, Al-Gorair S, et al. Effect of methotrexate on pulmonary function in patients with rheumatoid arthritis - a prospective study. Rheumatol Int 2002; 22: 204-207.
17. Beyeler C, Jordi B, Gerber NJ, Hof VIM. Pulmonary function in rheumatoid arthritis treated with low dose methotrexate: a longitudinal study. Br J Rheumatol 1996; 35: 446-452.
18. Pincus T, Brooks RH, Callahan LF. Prediction of long-term mortality in patients with rheumatoid arthritis according to simple questionnaire and joint count measures. Ann Intern Med 1994; 120: 26-34.
19. Gabriel SE, Crowson CS, Kremers HM, et al. Survival in rheumatoid arthritis. Arthritis Rheum 2003; 48: 54-58.
20. Wolfe F, Michaud K, Gefeller O, Choi HK. Predicting mortality in patients with rheumatoid arthritis. Arthritis Rheum 2003; 48: 1530-1542.
21. Choi HK, Hernan MA, Seeger JD, Robins JM, Wolfe F. Methotrexate and mortality in patients with rheumatoid arthritis. Lancet 2002; 359: 1173-1177.
22. Neas LM, Schwartz J. Pulmonary function levels as predictors of mortality in a national sample of US adults. Am J Epidemiol 1998; 147: 1011-1018.
23. Schunemann HJ, Dorn J, Grant BJB, Winkelstein W, Trevisan M. Pulmonary function is a long term predictor of mortality in the general population. 29-year follow up of the Buffalo health study. Chest 2000; 118: 656-664.
24. Mannino DM, Buist AS, Enright PL, Redd SC. Lung function and mortality in the United States: data from the first national health and nutrition examination survey follow up study. Torax 2003; 58: 388-393.
25. Kerstjens HAM, Rijcken B, Schouten J P, Postma DS. Decline of FEV1 by age and smoking status: facts, figures and fallacies. Torax 1997; 52: 820-827.